Editorial
doi: 10.1056/NEJMe068306.
Epub 2007 Feb 12.
Drug-eluting coronary stents--promise and uncertainty
- PMID: 17296828
- DOI: 10.1056/NEJMe068306
Item in Clipboard
Editorial
Drug-eluting coronary stents--promise and uncertainty
N Engl J Med.
.
No abstract available
Comment on
-
Stent thrombosis in randomized clinical trials of drug-eluting stents.N Engl J Med. 2007 Mar 8;356(10):1020-9. doi: 10.1056/NEJMoa067731. Epub 2007 Feb 12. N Engl J Med. 2007. PMID: 17296821
-
Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.N Engl J Med. 2007 Mar 8;356(10):1009-19. doi: 10.1056/NEJMoa067722. Epub 2007 Feb 12. N Engl J Med. 2007. PMID: 17296822
-
Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.N Engl J Med. 2007 Mar 8;356(10):1030-9. doi: 10.1056/NEJMoa067484. Epub 2007 Feb 12. N Engl J Med. 2007. PMID: 17296823
-
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.N Engl J Med. 2007 Mar 8;356(10):998-1008. doi: 10.1056/NEJMoa067193. Epub 2007 Feb 12. N Engl J Med. 2007. PMID: 17296824
-
A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents.N Engl J Med. 2007 Mar 8;356(10):989-97. doi: 10.1056/NEJMoa066633. Epub 2007 Feb 12. N Engl J Med. 2007. PMID: 17296825
-
Unanswered questions--drug-eluting stents and the risk of late thrombosis.N Engl J Med. 2007 Mar 8;356(10):981-4. doi: 10.1056/NEJMp068305. Epub 2007 Feb 12. N Engl J Med. 2007. PMID: 17296826 No abstract available.
-
Stent thrombosis redux--the FDA perspective.N Engl J Med. 2007 Mar 8;356(10):984-7. doi: 10.1056/NEJMp068304. Epub 2007 Feb 12. N Engl J Med. 2007. PMID: 17296827 No abstract available.
Similar articles
-
Unanswered questions--drug-eluting stents and the risk of late thrombosis.N Engl J Med. 2007 Mar 8;356(10):981-4. doi: 10.1056/NEJMp068305. Epub 2007 Feb 12. N Engl J Med. 2007. PMID: 17296826 No abstract available.
-
Drug-eluting stents is their future as bright as their past?J Am Coll Cardiol. 2007 Jul 10;50(2):146-8. doi: 10.1016/j.jacc.2007.04.028. Epub 2007 May 22. J Am Coll Cardiol. 2007. PMID: 17616298 No abstract available.
-
Debating the risks of drug-eluting stents.N Engl J Med. 2007 Jan 25;356(4):325-8. doi: 10.1056/NEJMp068300. N Engl J Med. 2007. PMID: 17251527 No abstract available.
-
Late and very late thrombosis of drug-eluting stents: evolving concepts and perspectives.J Am Coll Cardiol. 2007 Jul 10;50(2):119-27. doi: 10.1016/j.jacc.2007.04.031. Epub 2007 May 22. J Am Coll Cardiol. 2007. PMID: 17616295 Review.
-
Late thrombosis a concern with drug-eluting stents.J Interv Cardiol. 2007 Feb;20(1):26-9. doi: 10.1111/j.1540-8183.2007.00225.x. J Interv Cardiol. 2007. PMID: 17300394 Review. No abstract available.
Cited by
-
Coronary stent choice in patients with acute myocardial infarction.Curr Cardiol Rep. 2012 Aug;14(4):477-85. doi: 10.1007/s11886-012-0281-y. Curr Cardiol Rep. 2012. PMID: 22581167 Review.
-
The bridging function of clinical pharmacology.Eur J Clin Pharmacol. 2007 Sep;63(9):817-9. doi: 10.1007/s00228-007-0347-8. Eur J Clin Pharmacol. 2007. PMID: 17634934 No abstract available.
-
Another view of personalized medicine: optimizing stent selection on the basis of predicted benefit in percutaneous coronary intervention.Trends Cardiovasc Med. 2012 Jan;22(1):23-8. doi: 10.1016/j.tcm.2012.06.006. Epub 2012 Jul 28. Trends Cardiovasc Med. 2012. PMID: 22841840 Free PMC article. Review.
-
Should prophylactic low-dose aspirin therapy be continued in peptic ulcer bleeding?Drugs. 2011 Jan 1;71(1):1-10. doi: 10.2165/11585320-000000000-00000. Drugs. 2011. PMID: 21175237
-
Hemocompatibility of Super-Repellent surfaces: Current and Future.Mater Horiz. 2019 Oct 1;6(8):1596-1610. doi: 10.1039/C9MH00051H. Epub 2019 May 15. Mater Horiz. 2019. PMID: 31903188 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
